D Asboe
Overview
Explore the profile of D Asboe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Day S, Rae C, McOwan A, Wilkins R, Gray A, Harvey A, et al.
HIV Med
. 2024 Sep;
26(1):128-139.
PMID: 39279040
Objectives: Klick is a clinic-specific, digitally supported outpatient pathway of care for people living with HIV (PLWH). It involves a smartphone application (app) for PLWH to self-manage their care, navigate...
2.
Atkinson B, Spencer A, Onianwa O, Furneaux J, Grieves J, Nicholls I, et al.
J Hosp Infect
. 2023 Feb;
135:196-198.
PMID: 36842538
No abstract available.
3.
Stirrup O, Asboe D, Pozniak A, Sabin C, Gilson R, Mackie N, et al.
HIV Med
. 2020 Jan;
21(5):309-321.
PMID: 31927793
Objectives: The aim of the study was to investigate whether lamivudine (3TC) or emtricitabine (FTC) use following detection of M184V/I is associated with better virological outcomes. Methods: We identified people...
4.
Hibbert M, Crenna-Jennings W, Kirwan P, Benton L, Lut I, Okala S, et al.
AIDS Care
. 2018 May;
30(9):1189-1196.
PMID: 29806466
We aim to understand the difference in stigma and discrimination, in particular sexual rejection, experienced between gay and heterosexual men living with HIV in the UK. The People Living with...
5.
Barber T, Bansi L, Pozniak A, Asboe D, Nelson M, Moyle G, et al.
Int J STD AIDS
. 2016 Aug;
28(7):715-722.
PMID: 27510645
This study aimed to determine the prevalence of HIV neurocognitive impairment in HIV-infected men who have sex with men aged 18-50 years, using a simple battery of screening tests in...
6.
Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, et al.
HIV Med
. 2016 Aug;
18(3):204-213.
PMID: 27476929
Objectives: Transmission of drug-resistant HIV-1 has decreased in the UK since the early 2000s. This analysis reports recent trends and characteristics of transmitted drug resistance (TDR) in the UK from...
7.
Barber T, Moyle G, Hill A, Jagjit Singh G, Scourfield A, Yapa H, et al.
HIV Clin Trials
. 2016 Apr;
17(3):123-30.
PMID: 27125367
Background: Ongoing inflammation in controlled HIV infection contributes to non-AIDS comorbidities. High bilirubin appears to exhibit an anti-inflammatory effect in vivo. We therefore examined whether increased bilirubin in persons with...
8.
Nightingale A, Ratcliffe D, Leonidou L, Margetts A, Asboe D, Gazzard B, et al.
AIDS Care
. 2014 Mar;
26(8):1036-41.
PMID: 24625218
Despite ever improving advances in antiretroviral therapy, neurocognitive impairments such as asymptomatic and mild neurocognitive impairment remain a significant problem for the HIV-positive population. We distributed a post-neurocognitive impairment screening...
9.
Barber T, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, et al.
AIDS Care
. 2013 Jul;
26(2):160-8.
PMID: 23869661
With increasingly successful management of HIV, focus has shifted away from AIDS-related complications to other chronic co-morbidities. For HIV-related cognitive problems, the true aetiopathogenesis and epidemiology remains unclear. Rather than...
10.
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience
Waters L, Patterson B, Scourfield A, Hughes A, De Silva S, Gazzard B, et al.
Int J STD AIDS
. 2012 Aug;
23(8):546-52.
PMID: 22930290
The HIV-infected population is ageing. Issues including polypharmacy and co-morbidities led us to develop a dedicated clinic for HIV-infected individuals over 50. We describe our service evaluation after two years....